IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform.

Cell Death Discovery
Daisuke HaramaKanji Sugita

Abstract

The long-term prognosis of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) is still unsatisfactory even after the emergence of tyrosine kinase inhibitors (TKIs) against chimeric BCR-ABL, and this is associated with the high incidence of genetic alterations of Ikaros family zinc finger 1 (IKZF1), most frequently the hemi-allelic loss of exons 4-7 expressing a dominant-negative isoform Ik6. We found that lenalidomide (LEN), a representative of immunomodulatory drugs (IMiDs), which have been long used for the treatment of multiple myeloma, specifically induced accumulation of Ik6 with the disappearance of functional isoforms within 24 h (i.e., abrupt and complete shut-down of the IKZF1 activity) in Ik6-positive Ph+ALL cells in a neddylation-dependent manner. The functional IKZF3 isoforms expression was also abruptly and markedly downregulated. The LEN treatment specifically suppressed proliferation of Ik6-positive-Ph+ALL cells by inducing cell cycle arrest via downregulation of cyclins D3 and E and CDK2, and of importance, markedly upregulated their apoptosis in synergy with the TKI imatinib (IM). Apoptosis of IM-resistant Ph+ALL cells with T315I mutation of BCR-ABL was also upregulated by LEN in the prese...Continue Reading

References

Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianE J Freireich
Apr 2, 2005·Nature Reviews. Cancer·Ralf Küppers
Oct 18, 2005·Nature Structural & Molecular Biology·Christian SpeckBruce Stillman
Dec 14, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masamitsu YanadaUNKNOWN Japan Adult Leukemia Study Group
Jul 25, 2007·Journal of Cell Science·Rosalia CaballeroEsteban Ballestar
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Feb 1, 2008·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Tomofumi HoshinoJames Douglas Engel
Apr 15, 2008·Nature·Charles G MullighanJames R Downing
Mar 13, 2010·Science·Takumi ItoHiroshi Handa
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Renato BassanAlessandro Rambaldi
Sep 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maurizio AricòMaria Grazia Valsecchi
Sep 11, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Aline Tanguy-SchmidtXavier Thomas
Jun 12, 2013·European Journal of Haematology·Kenji TokunagaNorio Asou
Jul 29, 2015·Nature Communications·Kyung Yong LeeAnindya Dutta
Oct 7, 2015·Blood·Emma C Fink, Benjamin L Ebert
Feb 14, 2017·Nature·Lai N ChanMarkus Müschen
Feb 3, 2019·Cancer Science·Nobuhiko HaradaRitsuko Shimizu
Feb 20, 2019·JCI Insight·Guoxin ZhangJeremy N Rich
Sep 3, 2019·Neoplasia : an International Journal for Oncology Research·Marianne Samir Makboul IssacLouis A Gaboury

❮ Previous
Next ❯

Software Mentioned

GeneChip Operating Software
GeneSpring GX
CalcuSyn

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis